top of page

Combination of Three Therapies May Slow Progression of Advanced Melanoma

Three therapies—dabrafenib, trametinib, and pembrolizaumab—used in combination may slow advanced melanoma, according to a new study led by researchers at UCLA. Watch the video below for more information.

#Melanoma #dabrafenib #trametinib #andpembrolizaumabcan #UniversityofCaliforniaLosAngeles

10 views0 comments

Recent Posts

See All
bottom of page